| Year |
Citation |
Score |
| 2022 |
McCallin S, Menzi C, Lassen S, Daraspe J, Oechslin F, Moreillon P. Antibiotic Exposure Leads to Reduced Phage Susceptibility in Vancomycin Intermediate Staphylococcus aureus (VISA). Antimicrobial Agents and Chemotherapy. e0224721. PMID 35708333 DOI: 10.1128/aac.02247-21 |
0.315 |
|
| 2014 |
Entenza JM, Giddey M, Vouillamoz J, Moreillon P, Mancini S. Assessment of the in vitro synergy of daptomycin plus linezolid against multidrug-resistant enterococci. Journal of Global Antimicrobial Resistance. 2: 306-308. PMID 27873692 DOI: 10.1016/j.jgar.2014.09.004 |
0.305 |
|
| 2013 |
Oechslin F, Daraspe J, Giddey M, Moreillon P, Resch G. In vitro characterization of PlySK1249, a novel phage lysin, and assessment of its antibacterial activity in a mouse model of Streptococcus agalactiae bacteremia. Antimicrobial Agents and Chemotherapy. 57: 6276-83. PMID 24100496 DOI: 10.1128/Aac.01701-13 |
0.387 |
|
| 2013 |
Vouillamoz J, Entenza JM, Giddey M, Fischetti VA, Moreillon P, Resch G. Bactericidal synergism between daptomycin and the phage lysin Cpl-1 in a mouse model of pneumococcal bacteraemia. International Journal of Antimicrobial Agents. 42: 416-21. PMID 23992647 DOI: 10.1016/J.Ijantimicag.2013.06.020 |
0.33 |
|
| 2013 |
Veloso TR, Zbinden A, Andreoni F, Giddey M, Vouillamoz J, Moreillon P, Zinkernagel AS, Entenza JM. Streptococcus tigurinus is highly virulent in a rat model of experimental endocarditis. International Journal of Medical Microbiology : Ijmm. 303: 498-504. PMID 23856340 DOI: 10.1016/J.Ijmm.2013.06.006 |
0.353 |
|
| 2013 |
Guignard B, Vouillamoz J, Giddey M, Moreillon P. A positive interaction between inhibitors of protein synthesis and cefepime in the fight against methicillin-resistant Staphylococcus aureus European Journal of Clinical Microbiology & Infectious Diseases. 32: 899-907. PMID 23370969 DOI: 10.1007/S10096-013-1824-X |
0.356 |
|
| 2013 |
Veloso TR, Chaouch A, Roger T, Giddey M, Vouillamoz J, Majcherczyk P, Que YA, Rousson V, Moreillon P, Entenza JM. Use of a human-like low-grade bacteremia model of experimental endocarditis to study the role of staphylococcus aureus adhesins and platelet aggregation in early endocarditis Infection and Immunity. 81: 697-703. PMID 23250949 DOI: 10.1128/Iai.01030-12 |
0.334 |
|
| 2013 |
Stojanov M, Sakwinska O, Moreillon P. Expression of SCCmec cassette chromosome recombinases in methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis Journal of Antimicrobial Chemotherapy. 68: 749-757. PMID 23249841 DOI: 10.1093/Jac/Dks494 |
0.375 |
|
| 2012 |
Oppliger A, Moreillon P, Charrière N, Giddey M, Morisset D, Sakwinska O. Antimicrobial resistance of Staphylococcus aureus strains acquired by pig farmers from pigs. Applied and Environmental Microbiology. 78: 8010-4. PMID 22961904 DOI: 10.1128/Aem.01902-12 |
0.386 |
|
| 2012 |
Ythier M, Resch G, Waridel P, Panchaud A, Gfeller A, Majcherczyk P, Quadroni M, Moreillon P. Proteomic and transcriptomic profiling of Staphylococcus aureus surface LPXTG-proteins: correlation with agr genotypes and adherence phenotypes. Molecular & Cellular Proteomics : McP. 11: 1123-39. PMID 22843989 DOI: 10.1074/Mcp.M111.014191 |
0.329 |
|
| 2012 |
Rosin C, Bernsmeier C, Entenza JM, Moreillon P, Frei R, Weisser M, Flückiger U. Daptomycin for highly resistant Enterococcus faecium infection. Swiss Medical Weekly. 142: w13603. PMID 22736040 DOI: 10.4414/Smw.2012.13603 |
0.391 |
|
| 2012 |
Miró JM, Entenza JM, Del RÃo A, Velasco M, Castañeda X, Garcia de la Mà ria C, Giddey M, Armero Y, Pericà s JM, Cervera C, Mestres CA, Almela M, Falces C, Marco F, Moreillon P, et al. High-dose daptomycin plus fosfomycin is safe and effective in treating methicillin-susceptible and methicillin-resistant Staphylococcus aureus endocarditis. Antimicrobial Agents and Chemotherapy. 56: 4511-5. PMID 22644033 DOI: 10.1128/Aac.06449-11 |
0.405 |
|
| 2012 |
Dengler V, Meier PS, Heusser R, Kupferschmied P, Fazekas J, Friebe S, Staufer SB, Majcherczyk PA, Moreillon P, Berger-Bächi B, McCallum N. Deletion of hypothetical wall teichoic acid ligases in Staphylococcus aureus activates the cell wall stress response. Fems Microbiology Letters. 333: 109-20. PMID 22640011 DOI: 10.1111/J.1574-6968.2012.02603.X |
0.32 |
|
| 2012 |
Waridel P, Ythier M, Gfeller A, Moreillon P, Quadroni M. Evidence for a new post-translational modification in Staphylococcus aureus: hydroxymethylation of asparagine and glutamine. Journal of Proteomics. 75: 1742-51. PMID 22207155 DOI: 10.1016/J.Jprot.2011.12.014 |
0.329 |
|
| 2012 |
Moreillon P, Bizzini A, Giddey M, Vouillamoz J, Entenza JM. Vancomycin-intermediate Staphylococcus aureus selected during vancomycin therapy of experimental endocarditis are not detected by culture-based diagnostic procedures and persist after treatment arrest. The Journal of Antimicrobial Chemotherapy. 67: 652-60. PMID 22167243 DOI: 10.1093/Jac/Dkr521 |
0.363 |
|
| 2011 |
Danne C, Entenza JM, Mallet A, Briandet R, Débarbouillé M, Nato F, Glaser P, Jouvion G, Moreillon P, Trieu-Cuot P, Dramsi S. Molecular characterization of a Streptococcus gallolyticus genomic island encoding a pilus involved in endocarditis. The Journal of Infectious Diseases. 204: 1960-70. PMID 22043018 DOI: 10.1093/Infdis/Jir666 |
0.398 |
|
| 2011 |
Resch G, Moreillon P, Fischetti VA. PEGylating a bacteriophage endolysin inhibits its bactericidal activity. Amb Express. 1: 29. PMID 21982426 DOI: 10.1186/2191-0855-1-29 |
0.32 |
|
| 2011 |
Pea F, Cojutti P, Petrosillo N, Furlanut M, Entenza JM, Veloso TR, Vouillamoz J, Giddey M, Moreillon P. Continuous Infusion May Improve the Efficacy of Vancomycin in Treatment of Experimental Endocarditis Due to Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Antimicrobial Agents and Chemotherapy. 55: 4496-4497. PMID 21849572 DOI: 10.1128/Aac.00603-11 |
0.389 |
|
| 2011 |
Sakwinska O, Giddey M, Moreillon M, Morisset D, Waldvogel A, Moreillon P. Staphylococcus aureus host range and human-bovine host shift Applied and Environmental Microbiology. 77: 5908-5915. PMID 21742927 DOI: 10.1128/Aem.00238-11 |
0.383 |
|
| 2011 |
Entenza JM, Veloso TR, Vouillamoz J, Giddey M, Majcherczyk P, Moreillon P. In Vivo Synergism of Ceftobiprole and Vancomycin against Experimental Endocarditis Due to Vancomycin-Intermediate Staphylococcus aureus Antimicrobial Agents and Chemotherapy. 55: 3977-3984. PMID 21730114 DOI: 10.1128/Aac.00402-11 |
0.355 |
|
| 2011 |
Sakwinska O, Morisset D, Madec JY, Waldvogel A, Moreillon P, Haenni M. Link between genotype and antimicrobial resistance in bovine mastitis-related Staphylococcus aureus strains, determined by comparing swiss and French isolates from the Rhône Valley Applied and Environmental Microbiology. 77: 3428-3432. PMID 21421793 DOI: 10.1128/Aem.02468-10 |
0.377 |
|
| 2011 |
Veloso TR, Amiguet M, Rousson V, Giddey M, Vouillamoz J, Moreillon P, Entenza JM. Induction of experimental endocarditis by continuous low-grade bacteremia mimicking spontaneous bacteremia in humans Infection and Immunity. 79: 2006-2011. PMID 21321073 DOI: 10.1128/Iai.01208-10 |
0.359 |
|
| 2011 |
Entenza JM, Veloso TR, Vouillamoz J, Giddey M, Moreillon P. Failure of vancomycin continuous infusion against experimental endocarditis due to vancomycin-intermediate Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 55: 385-387. PMID 20956604 DOI: 10.1128/Aac.00811-10 |
0.332 |
|
| 2010 |
Sakwinska O, Blanc DS, Lazor-Blanchet C, Moreillon M, Giddey M, Moreillon P. Ecological temporal stability of Staphylococcus aureus nasal carriage. Journal of Clinical Microbiology. 48: 2724-8. PMID 20519475 DOI: 10.1128/Jcm.02091-09 |
0.342 |
|
| 2010 |
Buck AW, Fowler VG, Yongsunthon R, Liu J, DiBartola AC, Que YA, Moreillon P, Lower SK. Bonds between fibronectin and fibronectin-binding proteins on Staphylococcus aureus and Lactococcus lactis. Langmuir : the Acs Journal of Surfaces and Colloids. 26: 10764-70. PMID 20218549 DOI: 10.1021/La100549U |
0.305 |
|
| 2010 |
Entenza JM, Giddey M, Vouillamoz J, Moreillon P. In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin/clavulanic acid or ampicillin. International Journal of Antimicrobial Agents. 35: 451-6. PMID 20185277 DOI: 10.1016/J.Ijantimicag.2009.12.022 |
0.4 |
|
| 2010 |
Haenni M, Galofaro L, Ythier M, Giddey M, Majcherczyk P, Moreillon P, Madec JY. Penicillin-binding protein gene alterations in Streptococcus uberis isolates presenting decreased susceptibility to penicillin. Antimicrobial Agents and Chemotherapy. 54: 1140-5. PMID 20065061 DOI: 10.1128/Aac.00915-09 |
0.409 |
|
| 2010 |
Ythier M, Entenza JM, Bille J, Vandenesch F, Bes M, Moreillon P, Sakwinska O. Natural variability of in vitro adherence to fibrinogen and fibronectin does not correlate with in vivo infectivity of Staphylococcus aureus. Infection and Immunity. 78: 1711-6. PMID 20065030 DOI: 10.1128/Iai.01274-09 |
0.378 |
|
| 2010 |
Bizzini A, Entenza JM, Michielin O, Arnold I, Erni B, Moreillon P. A Single Mutation in Enzyme I of the Sugar Phosphotransferase System Confers Penicillin Tolerance to Streptococcus gordonii Antimicrobial Agents and Chemotherapy. 54: 259-266. PMID 19858257 DOI: 10.1128/Aac.00699-09 |
0.404 |
|
| 2009 |
Entenza JM, Haldimann A, Giddey M, Lociuro S, Hawser S, Moreillon P. Efficacy of iclaprim against wild-type and thymidine kinase-deficient methicillin-resistant Staphylococcus aureus isolates in an in vitro fibrin clot model. Antimicrobial Agents and Chemotherapy. 53: 3635-41. PMID 19564362 DOI: 10.1128/Aac.00325-09 |
0.384 |
|
| 2009 |
Panchaud A, Guy L, Collyn F, Haenni M, Nakata M, Podbielski A, Moreillon P, Roten CA. M-protein and other intrinsic virulence factors of Streptococcus pyogenes are encoded on an ancient pathogenicity island. Bmc Genomics. 10: 198. PMID 19397826 DOI: 10.1186/1471-2164-10-198 |
0.686 |
|
| 2009 |
Sakwinska O, Kuhn G, Balmelli C, Francioli P, Giddey M, Perreten V, Riesen A, Zysset F, Blanc DS, Moreillon P. Genetic diversity and ecological success of Staphylococcus aureus strains colonizing humans. Applied and Environmental Microbiology. 75: 175-83. PMID 18978084 DOI: 10.1128/Aem.01860-08 |
0.337 |
|
| 2009 |
Entenza J, Giddey M, Vouillamoz J, Moreillon P. 045 Combination Of Daptomycin With Ampicillin Prevents The Emergence Of Daptomycin-Resistant Enterococci In Vitro: An Alternative Treatment For Multi-Resistant Enterococcus Endocarditis? International Journal of Antimicrobial Agents. 33. DOI: 10.1016/S0924-8579(09)70064-0 |
0.353 |
|
| 2008 |
Majcherczyk PA, Barblan JL, Moreillon P, Entenza JM. Development of glycopeptide-intermediate resistance by Staphylococcus aureus leads to attenuated infectivity in a rat model of endocarditis. Microbial Pathogenesis. 45: 408-14. PMID 18930804 DOI: 10.1016/S0924-8579(07)70128-0 |
0.408 |
|
| 2008 |
Moreillon P. New and emerging treatment of Staphylococcus aureus infections in the hospital setting. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. 32-41. PMID 18318877 DOI: 10.1111/j.1469-0691.2008.01961.x |
0.319 |
|
| 2008 |
Vouillamoz J, Moreillon P, Giddey M, Entenza JM. In vitro activities of tigecycline combined with other antimicrobials against multiresistant gram-positive and gram-negative pathogens. The Journal of Antimicrobial Chemotherapy. 61: 371-4. PMID 18033780 DOI: 10.1093/Jac/Dkm459 |
0.351 |
|
| 2008 |
Haenni M, Moreillon P. Fitness cost and impaired survival in penicillin-resistant Streptococcus gordonii isolates selected in the laboratory. Antimicrobial Agents and Chemotherapy. 52: 337-9. PMID 17999969 DOI: 10.1128/Aac.00939-07 |
0.347 |
|
| 2007 |
Vankerckhoven V, Moreillon P, Piu S, Giddey M, Huys G, Vancanneyt M, Goossens H, Entenza JM. Infectivity of Lactobacillus rhamnosus and Lactobacillus paracasei isolates in a rat model of experimental endocarditis. Journal of Medical Microbiology. 56: 1017-1024. PMID 17644707 DOI: 10.1099/Jmm.0.46929-0 |
0.352 |
|
| 2007 |
Haenni M, Moreillon P, Lazarevic V. Promoter and transcription analysis of penicillin-binding protein genes in Streptococcus gordonii Antimicrobial Agents and Chemotherapy. 51: 2774-2783. PMID 17502405 DOI: 10.1128/Aac.01127-06 |
0.348 |
|
| 2007 |
Heying R, van de Gevel J, Que YA, Moreillon P, Beekhuizen H. Fibronectin-binding proteins and clumping factor A in Staphylococcus aureus experimental endocarditis: FnBPA is sufficient to activate human endothelial cells. Thrombosis and Haemostasis. 97: 617-26. PMID 17393025 DOI: 10.1160/Th06-11-0640 |
0.349 |
|
| 2007 |
Moreillon P, Wilson WR, Leclercq R, Entenza JM. Single-dose oral amoxicillin or linezolid for prophylaxis of experimental endocarditis due to vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis. Antimicrobial Agents and Chemotherapy. 51: 1661-5. PMID 17353251 DOI: 10.1128/Aac.00744-06 |
0.383 |
|
| 2007 |
Bizzini A, Entenza JM, Moreillon P. Loss of penicillin tolerance by inactivating the carbon catabolite repression determinant CcpA in Streptococcus gordonii Journal of Antimicrobial Chemotherapy. 59: 607-615. PMID 17327292 DOI: 10.1093/Jac/Dkm021 |
0.398 |
|
| 2006 |
Bizzini A, Beggah-Möller S, Moreillon P, Entenza JM. Lack of in vitro biofilm formation does not attenuate the virulence of Streptococcus gordonii in experimental endocarditis. Fems Immunology and Medical Microbiology. 48: 419-23. PMID 17087816 DOI: 10.1111/J.1574-695X.2006.00168.X |
0.343 |
|
| 2006 |
Vouillamoz J, Moreillon P, Giddey M, Entenza JM. Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci. The Journal of Antimicrobial Chemotherapy. 58: 1208-14. PMID 17030515 DOI: 10.1093/Jac/Dkl406 |
0.379 |
|
| 2006 |
Haenni M, Moreillon P. Mutations in penicillin-binding protein (PBP) genes and in non-PBP genes during selection of penicillin-resistant Streptococcus gordonii. Antimicrobial Agents and Chemotherapy. 50: 4053-61. PMID 17000741 DOI: 10.1128/Aac.00676-06 |
0.34 |
|
| 2006 |
Widmer E, Que YA, Entenza JM, Moreillon P. New concepts in the pathophysiology of infective endocarditis. Current Infectious Disease Reports. 8: 271-9. PMID 16822370 DOI: 10.1007/S11908-006-0071-Z |
0.328 |
|
| 2006 |
Aellen S, Que YA, Guignard B, Haenni M, Moreillon P. Detection of live and antibiotic-killed bacteria by quantitative real-time PCR of specific fragments of rRNA. Antimicrobial Agents and Chemotherapy. 50: 1913-20. PMID 16723545 DOI: 10.1128/Aac.00869-05 |
0.395 |
|
| 2005 |
Guy L, Karamata D, Moreillon P, Roten CA. Genometrics as an essential tool for the assembly of whole genome sequences: the example of the chromosome of Bifidobacterium longum NCC2705. Bmc Microbiology. 5: 60. PMID 16223444 DOI: 10.1186/1471-2180-5-60 |
0.672 |
|
| 2005 |
Guignard B, Entenza JM, Moreillon P. Beta-lactams against methicillin-resistant Staphylococcus aureus. Current Opinion in Pharmacology. 5: 479-89. PMID 16095969 DOI: 10.1016/J.Coph.2005.06.002 |
0.349 |
|
| 2005 |
Entenza JM, Moreillon P, Senn MM, Kormanec J, Dunman PM, Berger-Bächi B, Projan S, Bischoff M. Role of sigmaB in the expression of Staphylococcus aureus cell wall adhesins ClfA and FnbA and contribution to infectivity in a rat model of experimental endocarditis. Infection and Immunity. 73: 990-8. PMID 15664942 DOI: 10.1128/Iai.73.2.990-998.2005 |
0.359 |
|
| 2005 |
Rigoulay C, Entenza JM, Halpern D, Widmer E, Moreillon P, Poquet I, Gruss A. Comparative analysis of the roles of HtrA-like surface proteases in two virulent Staphylococcus aureus strains. Infection and Immunity. 73: 563-72. PMID 15618196 DOI: 10.1128/Iai.73.1.563-572.2005 |
0.377 |
|
| 2004 |
Vouillamoz J, Entenza JM, Hohl P, Moreillon P. LB11058, a new cephalosporin with high penicillin-binding protein 2a affinity and activity in experimental endocarditis due to homogeneously methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 48: 4322-7. PMID 15504859 DOI: 10.1128/Aac.48.11.4322-4327.2004 |
0.395 |
|
| 2004 |
Entenza JM, Vouillamoz J, Glauser MP, Moreillon P. Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci. Antimicrobial Agents and Chemotherapy. 48: 86-92. PMID 14693523 DOI: 10.1128/Aac.48.1.86-92.2004 |
0.433 |
|
| 2003 |
Weber JR, Moreillon P, Tuomanen EI. Innate sensors for Gram-positive bacteria. Current Opinion in Immunology. 15: 408-15. PMID 12900272 DOI: 10.1016/S0952-7915(03)00078-5 |
0.323 |
|
| 2003 |
Loeliger B, Caldelari I, Bizzini A, Meier PS, Majcherczyk PA, Moreillon P. Antibiotic-dependent correlation between drug-induced killing and loss of luminescence in Streptococcus gordonii expressing luciferase. Microbial Drug Resistance. 9: 123-131. PMID 12820796 DOI: 10.1089/107662903765826705 |
0.364 |
|
| 2003 |
Marchetti O, Moreillon P, Entenza JM, Vouillamoz J, Glauser MP, Bille J, Sanglard D. Fungicidal synergism of fluconazole and cyclosporine in Candida albicans is not dependent on multidrug efflux transporters encoded by the CDR1, CDR2, CaMDR1, and FLU1 genes. Antimicrobial Agents and Chemotherapy. 47: 1565-70. PMID 12709323 DOI: 10.1128/Aac.47.5.1565-1570.2003 |
0.326 |
|
| 2002 |
Entenza JM, Hohl P, Heinze-Krauss I, Glauser MP, Moreillon P. BAL9141, a Novel Extended-Spectrum Cephalosporin Active against Methicillin-Resistant Staphylococcus aureus in Treatment of Experimental Endocarditis Antimicrobial Agents and Chemotherapy. 46: 171-177. PMID 11751129 DOI: 10.1128/Aac.46.1.171-177.2002 |
0.418 |
|
| 2001 |
Entenza JM, Que YA, Vouillamoz J, Glauser MP, Moreillon P. Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance. Antimicrobial Agents and Chemotherapy. 45: 3076-3083. PMID 11600359 DOI: 10.1128/Aac.45.11.3076-3083.2001 |
0.405 |
|
| 2001 |
Cottagnoud P, Entenza JM, Cottagnoud M, Que Y, Moreillon P, Täuber MG. Sub-inhibitory concentrations of vancomycin prevent quinolone-resistance in a penicillin-resistant isolate of Streptococcus pneumoniae Bmc Microbiology. 1: 9-9. PMID 11454238 DOI: 10.1186/1471-2180-1-9 |
0.387 |
|
| 2000 |
Blanc DS, Pittet D, Ruef C, Widmer A, Zbinden R, Banuls AL, Hauser PM, Moreillon P, Francioli P, Tibayrenc M, Auckenthaler R, Bille J, Muhlemann K. Methicillin-resistant Staphylococcus aureus: Phylogenetic relatedness between European epidemic clones and Swiss sporadic strains Microbial Drug Resistance. 6: 231-238. PMID 11144423 DOI: 10.1089/Mdr.2000.6.231 |
0.341 |
|
| 2000 |
Marchetti O, Entenza JM, Sanglard D, Bille J, Glauser MP, Moreillon P. Fluconazole plus Cyclosporine: a Fungicidal Combination Effective against Experimental Endocarditis Due to Candida albicans Antimicrobial Agents and Chemotherapy. 44: 2932-2938. PMID 11036003 DOI: 10.1128/Aac.44.11.2932-2938.2000 |
0.316 |
|
| 2000 |
Caldelari I, Loeliger B, Langen H, Glauser MP, Moreillon P. Deregulation of the arginine deiminase (arc) operon in penicillin-tolerant mutants of Streptococcus gordonii. Antimicrobial Agents and Chemotherapy. 44: 2802-2810. PMID 10991863 DOI: 10.1128/Aac.44.10.2802-2810.2000 |
0.365 |
|
| 2000 |
Vouillamoz J, Entenza JM, Féger C, Glauser MP, Moreillon P. Quinupristin-Dalfopristin Combined with β-Lactams for Treatment of Experimental Endocarditis Due to Staphylococcus aureus Constitutively Resistant to Macrolide-Lincosamide-Streptogramin B Antibiotics Antimicrobial Agents and Chemotherapy. 44: 1789-1795. PMID 10858332 DOI: 10.1128/Aac.44.7.1789-1795.2000 |
0.36 |
|
| 2000 |
Que Y, Haefliger J, Francioli P, Moreillon P. Expression of Staphylococcus aureus clumping factor A in Lactococcus lactis subsp. cremoris using a new shuttle vector. Infection and Immunity. 68: 3516-3522. PMID 10816506 DOI: 10.1128/Iai.68.6.3516-3522.2000 |
0.361 |
|
| 1999 |
Entenza JM, Caldelari I, Glauser MP, Moreillon P. Efficacy of levofloxacin in the treatment of experimental endocarditis caused by viridans group streptococci Journal of Antimicrobial Chemotherapy. 44: 775-786. PMID 10590278 DOI: 10.1093/Jac/44.6.775 |
0.374 |
|
| 1999 |
Blanc DS, Petignat C, Moreillon P, Entenza JM, Eisenring M-, Kleiber H, Wenger A, Troillet N, Blanc C-, Francioli P. Unusual Spread of a Penicillin-Susceptible Methicillin-Resistant Staphylococcus aureus Clone in a Geographic Area of Low Incidence Clinical Infectious Diseases. 29: 1512-1518. PMID 10585805 DOI: 10.1086/313522 |
0.38 |
|
| 1999 |
Entenza JM, Vouillamoz J, Glauser MP, Moreillon P. Efficacy of Trovafloxacin in Treatment of Experimental Staphylococcal or Streptococcal Endocarditis Antimicrobial Agents and Chemotherapy. 43: 77-84. PMID 9869569 DOI: 10.1128/Aac.43.1.77 |
0.417 |
|
| 1998 |
Entenza JM, Marchetti O, Glauser MP, Moreillon P. Y-688, a New Quinolone Active against Quinolone-Resistant Staphylococcus aureus: Lack of In Vivo Efficacy in Experimental Endocarditis Antimicrobial Agents and Chemotherapy. 42: 1889-1894. PMID 9687379 DOI: 10.1128/Aac.42.8.1889 |
0.415 |
|
| 1998 |
Que Y, Entenza J, Francioli P, Moreillon P. The Impact of Penicillinase on Cefamandole Treatment and Prophylaxis of Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus aureus The Journal of Infectious Diseases. 177: 146-154. PMID 9419181 DOI: 10.1086/513805 |
0.402 |
|
| 1997 |
Entenza JM, Vouillamoz J, Glauser MP, Moreillon P. Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 41: 1662-1667. PMID 9257737 DOI: 10.1128/Aac.41.8.1662 |
0.426 |
|
| 1996 |
Blanc DS, Petignat C, Moreillon P, Wenger A, Bille J, Francioli P. Quantitative antibiogram as a typing method for the prospective epidemiological surveillance and control of MRSA: comparison with molecular typing. Infection Control and Hospital Epidemiology. 17: 654-659. PMID 8899439 DOI: 10.1086/647198 |
0.364 |
|
| 1996 |
Vermot D, Entenza JM, Vouillamoz J, Glauser MP, Moreillon P. Efficacy of clarithromycin versus that of clindamycin for single-dose prophylaxis of experimental streptococcal endocarditis. Antimicrobial Agents and Chemotherapy. 40: 809-811. PMID 8851620 DOI: 10.1128/Aac.40.3.809 |
0.327 |
|
| 1995 |
L'Hériteau F, Entenza JM, Lacassin F, Leport C, Glauser MP, Moreillon P. RP 59500 prophylaxis of experimental endocarditis due to erythromycin-susceptible and -resistant isogenic pairs of viridans group streptococci. Antimicrobial Agents and Chemotherapy. 39: 1425-1429. PMID 7492079 DOI: 10.1128/Aac.39.7.1425 |
0.443 |
|
| 1995 |
Entenza JM, Drugeon H, Glauser MP, Moreillon P. Treatment of experimental endocarditis due to erythromycin-susceptible or -resistant methicillin-resistant Staphylococcus aureus with RP 59500. Antimicrobial Agents and Chemotherapy. 39: 1419-1424. PMID 7492078 DOI: 10.1128/Aac.39.7.1419 |
0.419 |
|
| 1995 |
Entenza JM, Fluckiger U, Glauser MP, Moreillon P. Antibiotic treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis Medecine Et Maladies Infectieuses. 25: 1040. DOI: 10.1016/S0399-077X(05)80337-3 |
0.381 |
|
| 1994 |
Entenza JM, Fluckiger U, Glauser MP, Moreillon P. Antibiotic Treatment of Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus epidermidis The Journal of Infectious Diseases. 170: 100-109. PMID 8014483 DOI: 10.1093/Infdis/170.1.100 |
0.403 |
|
| 1994 |
Fluckiger U, Moreillon P, Blaser J, Bickle M, Glauser MP, Francioli P. Simulation of amoxicillin pharmacokinetics in humans for the prevention of streptococcal endocarditis in rats. Antimicrobial Agents and Chemotherapy. 38: 2846-2849. PMID 7695272 DOI: 10.1128/Aac.38.12.2846 |
0.339 |
|
| 1994 |
Entenza JM, Blatter M, Glauser MP, Moreillon P. Parenteral sparfloxacin compared with ceftriaxone in treatment of experimental endocarditis due to penicillin-susceptible and -resistant streptococci. Antimicrobial Agents and Chemotherapy. 38: 2683-2688. PMID 7695248 DOI: 10.1128/Aac.38.12.2683 |
0.438 |
|
| 1991 |
Moreillon P, Franciolli M, Cantoni L, Bille J, Glauser MP. Beta-lactam antibiotics active against methicillin-resistant Staphylococcus aureus. The Journal of Infectious Diseases. 163: 1165-1166. PMID 2064675 DOI: 10.1093/Infdis/163.5.1165 |
0.355 |
|
| 1991 |
Franciolli M, Bille J, Glauser MR, Moreillon P. β-Lactam Resistance Mechanisms of Methicillin-Resistant Staphylococcus aureus The Journal of Infectious Diseases. 163: 514-522. PMID 1995724 DOI: 10.1093/Infdis/163.3.514 |
0.416 |
|
| 1988 |
Moreillon P, Overholser CD, Malinverni R, Bille J, Glauser MP. Predictors of Endocarditis in Isolates from Cultures of Blood Following Dental Extractions in Rats with Periodontal Disease The Journal of Infectious Diseases. 157: 990-995. PMID 3361156 DOI: 10.1093/Infdis/157.5.990 |
0.332 |
|
| Show low-probability matches. |